Accessibility Menu
 
Absci logo

Absci

(NASDAQ) ABSI

Current Price$2.78
Market Cap$425.40M
Since IPO (2021)-87%
5 YearN/A
1 Year-1%
1 Month+1%

Absci Financials at a Glance

Market Cap

$425.40M

Revenue (TTM)

$2.80M

Net Income (TTM)

$115.18M

EPS (TTM)

$-0.85

P/E Ratio

-3.28

Dividend

$0.00

Beta (Volatility)

2.26 (High)

Price

$2.78

Volume

164,223

Open

$2.84

Previous Close

$2.78

Daily Range

$2.73 - $2.96

52-Week Range

$2.01 - $5.23

ABSI News

ABSI: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Absci

Industry

Biotechnology

Employees

140

CEO

Sean McClain

Headquarters

Vancouver, WA 98683, US

ABSI Financials

Key Financial Metrics (TTM)

Gross Margin

-13%

Operating Margin

-45%

Net Income Margin

-41%

Return on Equity

-63%

Return on Capital

-65%

Return on Assets

-53%

Earnings Yield

-30.49%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$425.40M

Shares Outstanding

153.02M

Volume

164.22K

Short Interest

0.00%

Avg. Volume

3.59M

Financials (TTM)

Gross Profit

$8.94M

Operating Income

$124.72M

EBITDA

$112.98M

Operating Cash Flow

$92.92M

Capital Expenditure

$1.11M

Free Cash Flow

$94.03M

Cash & ST Invst.

$144.29M

Total Debt

$5.30M

Absci Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$650.00K

-2.3%

Gross Profit

$2.18M

+86.6%

Gross Margin

-3.35%

N/A

Market Cap

$425.40M

N/A

Market Cap/Employee

$2.73M

N/A

Employees

156

N/A

Net Income

$29.56M

-2.0%

EBITDA

$34.21M

-36.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$138.99M

+35.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$2.62M

-53.9%

Short Term Debt

$2.68M

-39.4%

Return on Assets

-53.25%

N/A

Return on Invested Capital

-64.80%

N/A

Free Cash Flow

$29.08M

-71.2%

Operating Cash Flow

$29.18M

-72.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RGNXREGENXBIO Inc.
$7.76-6.05%
PRTAProthena Corporation plc
$9.26-2.73%
VSTMVerastem, Inc.
$5.04-4.73%
MGTXMeiraGTx Holdings plc
$7.62+1.20%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About ABSI

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.